Alnylam Pharmaceuticals, Inc. (ALNY): Price and Financial Metrics
Alnylam Pharmaceuticals, Inc. (ALNY)
Today's Latest Price: $117.66 USD
5.17 (4.60%)
Updated Feb 28 12:00am
Add ALNY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ALNY Stock Summary
- ALNY's price/sales ratio is 77.86; that's higher than the P/S ratio of 97.3% of US stocks.
- With a year-over-year growth in debt of 915.4%, Alnylam Pharmaceuticals Inc's debt growth rate surpasses 97.22% of about US stocks.
- Revenue growth over the past 12 months for Alnylam Pharmaceuticals Inc comes in at 84.21%, a number that bests 93.33% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Alnylam Pharmaceuticals Inc are GNTX, HRTX, FOLD, MXIM, and CLVS.
- ALNY's SEC filings can be seen here. And to visit Alnylam Pharmaceuticals Inc's official web site, go to www.alnylam.com.
ALNY Daily Price Range
ALNY 52-Week Price Range
ALNY Stock Price Chart More Charts
ALNY Price/Volume Stats
| Current price | $117.66 | 52-week high | $134.51 |
| Prev. close | $112.49 | 52-week low | $65.81 |
| Day low | $106.28 | Volume | 1,106,900 |
| Day high | $118.56 | Avg. volume | 692,930 |
| 50-day MA | $119.82 | Dividend yield | N/A |
| 200-day MA | $92.52 | Market Cap | 13.25B |
Alnylam Pharmaceuticals, Inc. (ALNY) Company Bio
Alnylam Pharmaceuticals is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company was founded in 2002 and is based in Cambridge, Massachusetts.
Top Stories View All
How Low Will Stocks Go?
Best & Worst Performing Stock Industries for February 28, 2020
Best & Worst Performing Small Cap Stocks for February 28, 2020
Best & Worst Performing Mid Cap Stocks for February 28, 2020
Best & Worst Performing Large Cap Stocks for February 28, 2020
View All Top Stories
Loading social stream, please wait...